多序列MRI影像组学预测脑转移瘤EGFR T790M突变
本研究回顾性纳入两院233例非小细胞肺癌脑转移患者,分别从T2WI、T2-FLAIR、DWI和T1-CE序列提取影像组学特征,构建随机森林模型预测T790M耐药突变。DWI模型表现最佳,训练集AUC 0.886、F1 0.789,测试集AUC 0.850、F1 0.743,DCA显示净获益最高。多序列MRI影像组学有潜力无创预测T790M突变。
要点
- DWI序列影像组学模型预测T790M突变性能最佳,测试集AUC达0.850。
- T2-FLAIR模型也有一定分类能力,多序列模型均可辅助预测。
- 该模型有望辅助筛选T790M突变患者以调整靶向治疗策略。
核心结论
- 基于多序列MRI的影像组学有潜力预测EGFR T790M耐药突变的出现,尤以DWI序列影像组学特征表现最佳。
研究设计与样本
- 回顾性研究,纳入两院233例经证实为非小细胞肺癌脑转移的患者(95例T790M突变,138例无T790M突变),分别作为训练集和测试集。
- 从T2WI、T2-FLAIR、DWI和T1-CE序列分别提取影像组学特征,基于最大信息系数和Boruta方法筛选特征。
- 采用随机森林分类器构建四个影像组学模型,以ROC曲线、F1分数和DCA曲线验证模型性能和临床效用。
诊断标准与关键数值
- DWI模型在训练集的AUC为0.886、F1分数为0.789,在测试集的AUC为0.850、F1分数为0.743。
- DCA曲线显示DWI模型在测试集的总体净获益高于其余三个模型。
- 其余三个模型在训练集和测试集均有一定分类能力,尤以T2-FLAIR模型较为突出。
临床应用与阅片要点
- 阅片时可关注DWI序列影像组学特征,其预测T790M突变效能最高,可辅助临床调整靶向治疗策略。
- 多序列MRI影像组学可作为无创预测工具,但需注意模型基于特定队列构建,尚未在常规报告中直接应用。
局限性
- 本研究为回顾性设计,样本来自两家医院,外部泛化能力有待进一步验证。
- 原文未报告影像组学模型在临床常规工作流中的前瞻性验证结果。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
RATIONALE AND OBJECTIVES: Timely identifying T790M mutation for non-small cell lung cancer (NSCLC) patients with brain metastases (BM) is essential to adjust targeted treatment strategies. To develop and validate radiomics models based on multisequence MRI for differentiating patients with T790M resistance from no T790M mutation in BM and explore the optimal sequence for prediction.
MATERIALS AND METHODS: This retrospective study enrolled 233 patients with proven of BM in NSCLC which included 95 with T790M and 138 without T790M from two hospitals as the training cohort and testing cohort separately. Radiomics features extracted from T2WI, T2 fluid-attenuated inversion recovery (T2-FLAIR), diffusion weighted imaging (DWI) and contrast-enhanced T1-weighted imaging (T1-CE) sequence respectively. The most predictable features were selected based on the maximal information coefficient and Boruta method. Then four radiomics models were built to characterize T790M mutation by random forest classifier. ROC curves, F1 score and DCA curves were constructed to validate the capability and verify the performance of four models.
RESULTS: The DWI model showed best performance with AUC and F1 score of 0.886 and 0.789 in the training cohort, 0.850 and 0.743 in the testing cohort. DCA curves also showed higher overall net benefit from the DWI model than from the remaining three models in the testing cohort. Other three models also had some classification power whether in the training or testing cohort, especially T2-FLAIR model.
CONCLUSION: Multisequence MRI-based radiomics has potential to predict the emergence of EGFR T790M resistance mutations especially the radiomics signature based on DWI sequence.
引用
- Li, Lv, Wang, et al. Predicting EGFR T790M Mutation in Brain Metastases Using Multisequence MRI-Based Radiomics Signature. Acad Radiol. 2022. PMID: 36586758. doi:10.1016/j.acra.2022.12.030
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。